Angiogenin is up‐regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival
- 17 March 2005
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 205 (5), 585-591
- https://doi.org/10.1002/path.1740
Abstract
Angiogenin, a 14.2 kD polypeptide that was originally noted for its angiogenic activity, is now increasingly recognized to have a multiplicity of biological roles in both physiological and pathological conditions. In breast cancer, there are conflicting studies questioning the role of angiogenin. Here, the pattern of expression of angiogenin during the transition from normal breast tissue to ductal carcinoma in situ and invasive carcinoma is reported together with the correlates between the level of angiogenin in 239 invasive carcinomas and standard clinicopathological parameters, hypoxia-inducible factor (HIF)-1α and the HIF-1α target gene DEC-1. This study shows that angiogenin expression is up-regulated in the cytoplasmic and nuclear compartments in in situ carcinoma and invasive carcinoma compared with normal breast tissue and that angiogenin expression in invasive carcinomas is significantly positively associated with high tumour grade (p = 0.03), positive oestrogen receptor (ER) status (p = 0.01), HIF-1α (p = 0.001) and DEC 1 (p = 0.001), but not with patient age (p = 0.8), tumour size (p = 0.25), lymph node status (p = 0.69), epidermal growth factor receptor (p = 0.56) or microvessel density (p = 0.32). No difference in relapse-free (p = 0.26) or overall (p = 0.63) survival was observed in patients stratified by angiogenin expression. This study suggests that angiogenin may be important in breast cancer progression and that, through its relationship with ER, it may be a target for tamoxifen. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancerThe Journal of Pathology, 2003
- The nuclear function of angiogenin in endothelial cells is related to rRNA productionBiochemical and Biophysical Research Communications, 2002
- Orthogonality of Calcium Concentration and Ability of 4,5-Diaminofluorescein to Detect NOJournal of Biological Chemistry, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Evidence for the Presence of Angiogenin in Human Follicular Fluid and the Up-Regulation of Its Production by Human Chorionic Gonadotropin and HypoxiaJournal of Clinical Endocrinology & Metabolism, 2000
- Regulation of Angiogenin Expression in Human HepG2 Hepatoma Cells by Mediators of the Acute-Phase ResponseBiochemical and Biophysical Research Communications, 1999
- Angiogenin Is Regulatedin Vivoas an Acute Phase ProteinBiochemical and Biophysical Research Communications, 1998
- Modulation by Bovine Angiogenin of Tubular Morphogenesis and Expression of Plasminogen Activator in Bovine Endothelial CellsBiochemical and Biophysical Research Communications, 1995
- Nuclear Translocation of Angiogenic Proteins in Endothelial Cells: An Essential Step in AngiogenesisBiochemistry, 1994
- Identification of the Nucleolar Targeting Signal of Human AngiogeninBiochemical and Biophysical Research Communications, 1994